Big Pharma At The Senate: When It Comes To Yes Or No Questions, There Are Still A Few Maybes
Our question-by-question infographic shows how Rx executives exhibited enough finesse to avoid any embarrassing sound bites at the Senate Finance Committee hearing on drug pricing.